AAM
MDCO

Alpine Associates Management’s Medicines Co MDCO Stock Holding History

Alpine Associates Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,590,435
Closed -$135M – 69
2019
Q4 		$135M Buy
+1,590,435
New +$106M 4.3% 8

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Alpine Associates Management's MDCO Position: Q1 2020 in Review

Alpine Associates Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,590,435 shares — an estimated $135M sold.

Alpine Associates Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $135M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Alpine Associates Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Alpine Associates Management sold 1,590,435 Medicines Co shares in Q1 2020, an estimated $135M.
  • Alpine Associates Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Alpine Associates Management's Medicines Co position peaked at $135M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Alpine Associates Management's 13F filing for Q1 2020, filed 12 May 2020.